CD154 inhibits tumor-induced apoptosis in dendritic cells and tumor growth

European Journal of Immunology

Volumn 29, Issue 7, 1999, Pages 2148-2155

  Esche, Clemens ^a   Gambotto, Andrea ^a   Satoh, Yuji ^a   Gerein, Valentin ^a   Robbins, Paul D ^a   Watkins, Simon C ^a   Lotze, Michael T ^a   Shurin, Michael R ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; CD154; Dendritic cell; IL 12; Immunotherapy

Indexed keywords

CD8 ANTIGEN; CELL ANTIGEN; GLYCOPROTEIN P 15095; INTERLEUKIN 12;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CONTROLLED STUDY; DENDRITIC CELL; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; CD40 LIGAND; CD8-POSITIVE T-LYMPHOCYTES; COLONIC NEOPLASMS; DENDRITIC CELLS; HUMANS; IMMUNOTHERAPY; INTEGRIN ALPHAXBETA2; INTERLEUKIN-12; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; TRANSDUCTION, GENETIC;

EID: 0033067460     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199907)29:07<2148::AID-IMMU2148>3.0.CO;2-F     Document Type: Article

References (26)

1. Esche, C., Shurin, M. R. and Lotze, M. T., The use of dendritic cells for cancer vaccination. Curr. Opin. Mol. Ther. 1999. 1: 72-81.
2. Shurin, M. R., Dendritic cells presenting tumor antigen. Cancer Immunol. Immunother. 1996. 43: 158-164.
3. Baker, S. J. and Reddy, E. P., Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogens 1996. 12: 1-9.
4. Alderson, M. R., Armitage, R. J., Tough, T. W., Strockbine, L., Fanslow, W. C. and Spriggs, M. K., CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J. Exp. Med. 1993. 178: 669-674.
5. Caux, C., Massacrier, C., Vanbervliet, B., Dubois, C., Van Kooten, C., Durand, I. and Banchereau, J., Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 1994. 180: 1263-1272.
6. Ludewig, B., Graf, D., Gelderblom, H. R., Becker, Y., Kroczek, R. A. and Paulie, G., Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40-ligand) and TNF-α, but strongly enhanced by interleukin-10. Eur. J. Immunol. 1995. 25: 1943-1950.
7. L expression and blocking oxidant accumulation. Am. J. Physiol. 1997. 272: C950-956.
8. Dilloo, D., Brown, M., Roskrow, M., Zhong, W., Holladay, M., Holden, W. and Brenner, M., CD40 ligand induces an antileukemia immune response in vivo. Blood 1997. 90: 1927-1933.
9. Grossmann, M. E., Brown, M. P. and Brenner, M. K., Antitumor responses induced by transgenic expression of CD40 ligand. Hum. Gene Ther. 1997. 8: 1935-1943.
10. Couderc, B., Zitvogel, L., Douchin-Echinard, V., Djennane, L., Tahara, H., Favre, G., Lotze, M. T. and Robbins, P. D., Enhancement of antitumor immunity by expression of CD70 (CD27 ligand) or CD154 (CD40 ligand) costimulatory molecules in tumor cells. Cancer Gene Ther. 1998. 5: 163-175.
11. Esche, C., Lokshin, A., Shurin, G. V., Gastman, B. R., Rabinowich, H., Watkins, S. C., Lotze, M. T. and Shurin, M. R., Tumor's other immune targets: dendritic cells. J. Leukoc. Biol. 1999. In press.
12. Lotze, M. T., Getting the source: dendritic cells as therapeutic reagents for the treatment of patients with cancer. Ann. Surg. 1997. 226: 1-5.
13. Kavanaugh, D. Y. and Carbone, D. P., Immunologic dysfunction in cancer. Hematol. Oncol. Clin. North Am. 1996. 10: 927-951.
14. Chen, L., Ashe, S., Brady, W. A., Hellstroem, I., Hellstroem, K. E., Ledbetter, J. A., McGowan, P. and Linsley, P. S., Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 1992. 71: 1093-1102.
15. Restifo, N. P., Esquivel, F., Kawakami, Y., Yewdell, J. W., Mule, J. J., Rosenberg, S. A. and Bennink, J. R., Identification of human cancers deficient in antigen processing. J. Exp. Med 1993. 177: 265-272.
16. Wojtowicz-Praga, S., Reversal of tumor-induced immunosuppression: a new approach to cancer therapy. J. Immunother. 1997. 20: 165-177.
17. Shurin, M. R., Esche, C., Lokshin, A. and Lotze, M. T., Apoptosis in dendritic cells. In: Lotze, M. T., Thomson, A. W. (Eds.) Dendritic cells. Biology and clinical applications. Academic Press, San Diego 1999, pp 673-692.
18. Koch, F., Stanzl, U., Jennewein, P., Janke, K., Heufler, C., Kämpgen, E., Romani, N. and Schuler, G., High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and down-regulation by IL-4 and IL-10. J. Exp. Med. 1996. 184: 741-746.
19. Cella, M., Scheidegger, D., Palmer-Lehmann, K., Lane, P., Lanzavecchia, A. and Alber, G., Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 1996. 184: 747-752.
20. + T cells. J. Immunol. 1995. 154: 5071-5079.
21. Shurin, M. R., Esche, C., Peron, J. M. and Lotze, M. T., Anti-tumor activities of Interleukin-12 and mechanisms of action. Chem. Immunol. 1997. 68: 153-174.
22. Stoppacciaro, A., Paglia, P., Lombardi, L., Parmiani, G., Baroni, C. and Colombo, M. P., Genetic modification of a carcinoma with the IL-4 gene increases the influx of dendritic cells relative to other cytokines. Eur J. Immunol. 1997. 27: 2375-2382.
23. Esche, C., Subbotin, V. M., Maliszewski, C., Lotze, M. T. and Shurin, M. R., FLT3 ligand administration inhibits tumor growth in murine melanoma and lymphoma. Cancer Res. 1998. 58: 380-383.
24. Peron, J. M., Esche, C., Subbotin, V. M., Maliszewski, C., Lotze, M. T. and Shurin, M. R., FLT3-Ligand administration inhibits liver metastases: role of NK cells. J. Immunol. 1998. 161: 6164-6170.
25. Shurin, M. R., Pandharipande, P. P., Zorina, T. D., Haluszczak, C., Subbotin, V. M., Hunter, O., Brumfield, A., Storkus, W., Maraskovsky, E. and Lotze, M. T., FLT3 ligand induces the generation of functionally active dendritic cells in mice. Cell. Immunol. 1997. 179: 174-184.
26. Matzinger, P., The JAM test. A simple assay for DNA fragmentation and cell death. J. Immunol. Methods 1991. 145: 185-192.